Medline ® Abstract for Reference 30
of 'First-line chemotherapy for advanced (stage III or IV) epithelial ovarian, fallopian tubal, and peritoneal cancer'
Patient-reported outcomes of a phase III clinical trial of bevacizumab with IV versus IP chemotherapy in ovarian, fallopian tube, and primary peritoneal carcinoma
Huang H, Walker J, Brady MF, DiSilvestro PA
Annual Meeting on Women's Cancer..2016